CD79a-EP82

Tonsil stained with Anti-CD79a

CD79a-EP82

CD79 consists of two proteins: CD79a (mb-1) and CD79b (B29). CD79a recognizes the Ig-alpha protein, and CD79b recognizes the Ig-beta protein of the B-cell antigen component of the B-lymphocyte antigen receptor. The expression of CD79 precedes immunoglobulin (Ig) gene, heavy-chain gene rearrangement and CD20 expression. In precursor B-cells, the CD79 protein chains are already expressed in the cytoplasm (CyCD79). Surface expression of CD79 begins at the pro-B-cell stage and persists throughout the B-cell differentiation, and continues presents on plasma cells. CD79a is an excellent marker for identification of normal and neoplastic B-lymphocytes.

  • Description
  • Specifications
  • Ordering Information
  • Publications

CD79 consists of two proteins: CD79a (mb-1) and CD79b (B29). CD79a recognizes the Ig-alpha protein, and CD79b recognizes the Ig-beta protein of the B-cell antigen component of the B-lymphocyte antigen receptor. The expression of CD79 precedes immunoglobulin (Ig) gene, heavy-chain gene rearrangement and CD20 expression. In precursor B-cells, the CD79 protein chains are already expressed in the cytoplasm (CyCD79). Surface expression of CD79 begins at the pro-B-cell stage and persists throughout the B-cell differentiation, and continues presents on plasma cells. CD79a is an excellent marker for identification of normal and neoplastic B-lymphocytes.

  • Source
    Rabbit Monoclonal
  • Clone
    EP82
  • Class
    IVD
  • Isotype
    Rabbit IgG
  • Tested Reactivity
    Human,FFPE
  • Localization
    Membranous, Cytoplasmic
  • Positive Control
    Tonsil, B Cell Lymphoma
  • Catalog
    Pack Size
  • PR026-3ml
    3 ml(RTU)
  • PR026-6ml
    6 ml(RTU)
  • CR026-0.1ml
    0.1 ml(Conc.)
  • CR026-0.5ml
    0.5 ml(Conc.)
  • HAR026-3ml
    3 ml(RTU)
  • HAR026-6ml
    6 ml(RTU)
  • CR026 - 1ml
    1ml ( Conc. )

  1. Histomorphometric and immunohistochemical details of hemal nodes in Indian buffalo
    https://www.entomoljournal.com/archives/2019/vol7issue2/PartG/7-2-25-665.pdf